AU4425593A - New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides - Google Patents

New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides

Info

Publication number
AU4425593A
AU4425593A AU44255/93A AU4425593A AU4425593A AU 4425593 A AU4425593 A AU 4425593A AU 44255/93 A AU44255/93 A AU 44255/93A AU 4425593 A AU4425593 A AU 4425593A AU 4425593 A AU4425593 A AU 4425593A
Authority
AU
Australia
Prior art keywords
cycloalkylacetamides
quinolylmethoxyphenyl
methanesulphonyl
substituted
isobutyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU44255/93A
Other versions
AU669913B2 (en
Inventor
Romanis Fruchtmann
Armin Dr Hatzelmann
Michael Dr Matzke
Klaus-Helmut Dr Mohrs
Reiner Prof Dr Muller-Peddinghaus
Siegfried Dr Raddatz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU4425593A publication Critical patent/AU4425593A/en
Application granted granted Critical
Publication of AU669913B2 publication Critical patent/AU669913B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU44255/93A 1992-08-12 1993-07-28 New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides Ceased AU669913B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4226649A DE4226649A1 (en) 1992-08-12 1992-08-12 New isobutyl-substituted methanesulfonyl-quinolylmethoxyphenyl-cycloalkylacetic acid aminols
DE4226649 1992-08-12

Publications (2)

Publication Number Publication Date
AU4425593A true AU4425593A (en) 1994-02-17
AU669913B2 AU669913B2 (en) 1996-06-27

Family

ID=6465373

Family Applications (1)

Application Number Title Priority Date Filing Date
AU44255/93A Ceased AU669913B2 (en) 1992-08-12 1993-07-28 New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides

Country Status (19)

Country Link
EP (1) EP0582916A1 (en)
JP (1) JPH06157462A (en)
KR (1) KR940003937A (en)
CN (1) CN1039998C (en)
AU (1) AU669913B2 (en)
CA (1) CA2103600A1 (en)
CZ (1) CZ282341B6 (en)
DE (1) DE4226649A1 (en)
FI (1) FI933529A (en)
HU (1) HUT70171A (en)
IL (1) IL106623A0 (en)
MX (1) MX9304608A (en)
MY (1) MY108716A (en)
NO (1) NO179948C (en)
NZ (1) NZ248350A (en)
PL (1) PL174102B1 (en)
RU (1) RU2103261C1 (en)
SK (1) SK86693A3 (en)
ZA (1) ZA935828B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4443891A1 (en) 1994-12-09 1996-06-13 Bayer Ag Heterocyclically substituted oxy-phenyl- (phenyl) glycinolamides
DE4443892A1 (en) * 1994-12-09 1996-06-13 Bayer Ag 4- (Quinolin-2-yl-methoxy) phenyl acetic acid derivatives
US5931170A (en) * 1998-10-08 1999-08-03 Addway Engineering Limited Dental flosser

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3814504A1 (en) * 1988-04-29 1989-11-09 Bayer Ag (ALPHA) -SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS AND SITES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE IN MEDICAMENTS
DE3900261A1 (en) * 1988-05-31 1989-12-07 Bayer Ag SUBSTITUTED 4- (CHINOLIN-2-YL-METHOXY) PHENYL-ACETIC ACID DERIVATIVES
DE3916663A1 (en) * 1989-05-23 1990-11-29 Bayer Ag SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL-ACYL-SULPHONAMIDES AND CYANAMIDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICAMENTS
DE4105551A1 (en) * 1991-02-22 1992-08-27 Bayer Ag 2-SUBSTITUTED CHINOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE IN MEDICINAL PRODUCTS
DE4112533A1 (en) * 1991-04-17 1992-10-22 Bayer Ag METHOD FOR THE PRODUCTION OF ENANTIOMER-PURE SUBSTITUTED (CHINOLIN-2-YL-METHOXY) PHENYL ACETIC ACIDS

Also Published As

Publication number Publication date
CZ163693A3 (en) 1994-03-16
HUT70171A (en) 1995-09-28
IL106623A0 (en) 1993-12-08
DE4226649A1 (en) 1994-02-17
ZA935828B (en) 1994-03-10
PL300025A1 (en) 1994-03-21
EP0582916A1 (en) 1994-02-16
SK86693A3 (en) 1994-09-07
JPH06157462A (en) 1994-06-03
FI933529A (en) 1994-02-13
CN1087084A (en) 1994-05-25
NO932731D0 (en) 1993-07-29
NO179948C (en) 1997-01-15
CZ282341B6 (en) 1997-07-16
CA2103600A1 (en) 1994-02-13
HU9302320D0 (en) 1993-10-28
FI933529A0 (en) 1993-08-10
MX9304608A (en) 1994-02-28
NO179948B (en) 1996-10-07
RU2103261C1 (en) 1998-01-27
NO932731L (en) 1994-02-14
CN1039998C (en) 1998-09-30
KR940003937A (en) 1994-03-14
PL174102B1 (en) 1998-06-30
AU669913B2 (en) 1996-06-27
MY108716A (en) 1996-11-30
NZ248350A (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU4166393A (en) Auto-reclosers
AU6001594A (en) Imidazoazines
AU3561193A (en) TNF-muteins
AU3991693A (en) Pyrazinoindoles
AU3803593A (en) Compounds
AU3042892A (en) Rockbolt
AU4177593A (en) Benzophenonehydrazones
AU685767B2 (en) Substituted benzazepinones
AU667580B2 (en) Line-handling block
AU4156393A (en) Heterocyclyltriazolinones
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU664253B2 (en) Photo-deviometer
AU3461693A (en) Saddle-cloth
AU3562193A (en) Morpholin- and thiomorpholin-4-ylamides
AU5063493A (en) Fitting
AU4164793A (en) Heterocyclyltriazolinones
AU4632493A (en) Weathershed
AU1274295A (en) Heteroarylpyrroles
AU3048492A (en) New compounds
AU4864693A (en) Alkoxymethyl-substituted pyridonebiphenyls
AU3185693A (en) Pyrrolylbenzodiazepinones
AU4425593A (en) New isobutyl-substituted methanesulphonyl-quinolylmethoxyphenyl-cycloalkylacetamides
AU4316993A (en) Polyaniles
AU5564794A (en) Play-mark

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired